Despite the huge contraction in global GDP caused by the Covid-19 pandemic, the Lithuanian life sciences sector grew by almost 87% last year. Life sciences companies generated revenues of approximately €2 billion: 2.5% of the country’s GDP.

Why do large companies and start-ups choose the Baltic country for their R&D?